Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2,

Christian Zimmermann1, Koen van de Wetering, Evita van de Steeg

  • 1Division of Experimental Therapy, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

Insights

Species-specific differences exist between human and mouse multidrug resistance protein 2 (MRP2/Mrp2) transporters. These variations impact drug transport and interactions, crucial for extrapolating mouse study results to human pharmacokinetics.

Area of Science:

  • Pharmacology
  • Biochemistry
  • Drug Metabolism

Background:

  • Multidrug resistance protein 2 (MRP2/Mrp2) is a key transporter affecting drug pharmacokinetics.
  • Mouse Mrp2 knockout models are used for in vivo drug studies.
  • Understanding species-specific transporter differences is vital for drug development.

Purpose of the Study:

  • To investigate species-specific differences between human MRP2 and mouse Mrp2.
  • To assess the transport of clinically relevant drugs by human MRP2 and mouse Mrp2.
  • To evaluate drug-drug interactions involving MRP2/Mrp2 modulation.

Main Methods:

  • Generation of polarized cell lines expressing human MRP2 or mouse Mrp2.
  • Assessment of drug transport using these cell lines and vesicular transport studies.
  • Evaluation of modulatory effects of probenecid, sulfanitran, and sulfinpyrazone.

Main Results:

  • Mouse Mrp2 transported saquinavir and docetaxel more efficiently; human MRP2 transported vinblastine better.
  • Probenecid and sulfanitran differentially stimulated MRP2/Mrp2-mediated transport, often more for human MRP2.
  • Sulfinpyrazone exhibited opposing effects, stimulating human MRP2 while inhibiting mouse Mrp2.

Conclusions:

  • Human and mouse MRP2/Mrp2 share overlapping substrate specificities but exhibit significant differences in transport efficiency.
  • Species-specific variations in MRP2/Mrp2 function and modulation by other compounds are evident.
  • These transporter differences necessitate careful consideration when extrapolating mouse pharmacokinetic data to humans.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
Membrane Transporters01:31

Membrane Transporters

Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport01:19

Drug Absorption Mechanism: Carrier-Mediated Membrane Transport

Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
ABC Transporters: Importer01:27

ABC Transporters: Importer

ATP-binding cassette or ABC transporters are a class of ATP-driven pumps that hydrolyze ATP to move solutes across the membrane. They can be grouped into importers and exporters. While exporters are present in all domains of life, importers exist only in bacteria and some plants.
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types: